Prostate cancer ranks as the most prevalent form of cancer among men, following only skin cancer in diagnosis frequency. Upon receiving a diagnosis, comprehending the available treatment options ...

NEW YORK (Reuters Health) - One in 15 people undergoing robot-assisted prostate, kidney or bladder surgery develops a nerve injury related to pressure from positioning on the operating table, a new ...

In an advancement for minimally invasive care, a first-ever procedure using two separate surgery robots was successfully completed. A urologist at the University of Texas (UT) Southwestern Medical ...

NEW YORK (Reuters Health) - Considering having a surgeon remove your cancerous prostate using a robot? You might want to see a surgeon who has done at least 80 operations for the best results, ...

When it comes to treatment for prostate cancer, men have a range of options, from active surveillance to radiation to surgery, just to name a few. Which approach to choose is a highly personal ...

Surgery utilizes Levita MARS Platform and its Dynamic Magnetic Positioning™ technology and Da Vinci Single Port Robotic System to deliver unprecedented precision and set a new standard for minimally ...

Although minimally invasive prostate removal aided by a robot can lead to less blood loss, shorter hospital stays and fewer complications, there is no evidence that the procedure improves cure rates, ...

Robotic surgery is a promising option in the field of prostate cancer, leading to better outcomes and shorter hospital stays. Robotic surgery can have a multitude of benefits for patients who are ...

This content is sponsored by MedStar Washington Hospital Center. Prostate cancer is the most common cancer among men (after skin cancer), but it can often be treated successfully. It affects the ...

Prostate cancer is the most common cancer among men in the US, aside from skin cancer. About 13% of male Americans will get it — and treatment often comes with the risk of erectile dysfunction. Relief ...

The arrival of robotics in surgery has been a roller coaster ride, offering another lesson in how technology in healthcare, unlike most industries, faces challenges to show it’s better than the status ...

At 24 months' follow-up, the only phase 3 randomized clinical trial to directly compare functional and oncologic outcomes between robot-assisted laparoscopic prostatectomy and open radical retropubic ...